ArticleOncoTargets and therapy2020

Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study.

Andrea Forschner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.